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uterus in sagittal plane and, afterwards, utilizing the 
automatic ultrasound array to sweep over the region of 
interest. 
Conclusions: The quality of the ultrasound images using the 
3D probe was superior to the images of the 2D probe. 
Moreover, the uterine capture, using the 3D probe required 
less effort than the cumbersome 2D probe. In summary, the 
3D probe is a user-friendly and promising alternative as an 
IGRT system for GYN patients in radiotherapy. 
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Purpose/Objective: DIBH can reduce heart dose when 
planning breast RT versus free breathing. Whilst reducing 
heart dose is an important clinical objective, DIBH must 
support accurate and reproducible treatment. Inspired lung 
volume (VInsp) variation was considered an important variable 
in terms of the impact on set-up accuracy in the DIBH 
setting. The Varian Real Time Position Management system 
(RPM) uses a reflective marker block that when positioned on 
the patient acts as a respiratory surrogate. The aim of this 
study was to measure the variation of VInsp when performing 
DIBH with the Varian RPM over a treatment course.  
Materials and Methods: 10 staff volunteers were positioned 
supine on a 15° inclined breast board with both arms raised. 
The RPM marker block was localised on midline where 
vertical movement was observed during DIBH coaching. Three 
DIBHs were acquired within a preparatory session and the 
largest amplitude selected to set the reference threshold. 
From this the volunteer was visually coached to acquire the 
reference DIBH, simulating a 'planning' CT. Each volunteer 
attended 8 subsequent 'treatment' sessions where they were 
visually coached to perform 3 DIBHs to the reference 
amplitude (5mm threshold). For all sessions, VInsp was 
measured with the SDX® DynR spirometer. Systematic and 
random error was calculated by analysing the mean and 
standard deviations of the VInsp for each individual and the 
entire cohort. Variation was measured as a percentage 
difference from the reference VInsp.  
Results: All volunteers performed 25 second DIBHs with 
minimal coaching, meeting their RPM amplitude (5mm 
threshold) for all sessions. Mean time between reference 
session and first treatment was 14.1 days (range 5 - 28). 
Mean time to acquire 8 treatment sessions was 72 days (range 
35 - 105). 10 reference and 240 treatment DIBH's were 
acquired. Mean reference RPM amplitude was 21.8mm (range 
12.2 - 32.2). Mean reference VInsp was 1.94 litres (range 1.41 - 
3.44). Mean total VInsp variation for treatment compared to 
the reference sessions for the population was 22% (range 0% – 
100%). The systematic error in VInsp between reference and 
treatment sessions for the population was 30% (individual 
systematic error varied from -25% to 74%) and random error 
between the reference and treatment sessions for the 
population was 14% (range 5% - 24%). The population mean 
was 1%, showing there was no systematic directional error in 
Vinsp for the cohort.  
 
 
 
Conclusions: DIBH with the Varian RPM is associated with a 
variation in the volume of air inspired over a treatment 
course and compared to the reference. The impact of this 
variation on the dose planned versus that delivered needs 
further prospective evaluation. Quantifying the dosimetric 
effect on the heart, lungs, tumour bed and ipsilateral breast 
when using the Varian RPM for DIBH breast radiotherapy is 
recommended. 
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Purpose/Objective: To assess suitability of lung margins 
following analysis of set up data from patients recruited 
within the Concurrent ONce-daily VErsus twice-daily 
RadioTherapy (CONVERT) Trial: A 2-arm randomised 
controlled trial of concurrent chemo-radiotherapy comparing 
twice-daily and once-daily radiotherapy schedules in patients 
with limited stage small cell lung cancer (SCLC) and good 
performance status (grade 0 to grade 1). Margins outlined 
within the CONVERT trial define the clinical target volume 
(CTV) as the gross tumour volume (GTV) + 0.5cm in all 
directions and the planning target volume (PTV) as the CTV + 
0.8cm anterior-posterior (A/P) and left-right (L/R) plane, and 
1.0cm in the superior-inferior (S/I) plane. The impact of 
gender or immobilisation device on margins was also 
assessed. 
Materials and Methods: At this institution ninety patients 
were recruited, planned and treated within the CONVERT 
trial. Patients were treated supine, either with a 5 point 
immobilisation shell or with both arms positioned above their 
head on a lung board. Knee bolsters were used for added 
comfort. Cone Beam Computed Tomography (CBCT) images 
using Elekta Synergy TM – version 4.5 were acquired during 
treatment for the first 3 fractions and then at least weekly 
thereafter following a systematic error reduction strategy 
